PG 106

PG 106 is a selective antagonist of human melanocortin receptor 3 (hMC3R), and shows no activity at hMC4 receptors and hMC5 receptors. Therefore, it may be used to differentiate the substructural features responsible for selectivity at the hMC3R, hMC4R, and hMC5R.

Online Inquiry

CAT#R0980
CAS944111-22-2
M.F/FormulaC51H69N13O9
M.W/Mr.1008.19
SequenceXDXXRWK(Modifications: X-1 = Ac-Nle, X-3 = beta-Ala, X-4 = D-2-Nal, Lys-7 = C-terminal amide, Asp-2, Lys-7, Cyclized)
Labeling TargetHuman melanocortin receptor 3 (hMC3R)
AppearanceWhite lyophilised solid
Purity>98%
ActivityAntagonist
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

of skin aging  Natural aging of the skin results in decreased production and increased degradation of extracellu ...

 JIP1, a member of the JIPs family, was first discovered to promote JNK activation by combining multiple componen ...

Antioxidant effect of peptides  Peptides have been isolated from the resultant by-products in the past 15 years and suggested ...

  Secretin belongs to the vasoactive intestinal peptide/pituitary adenylate cyclase activating peptide family an ...

 GR 82334 is a spirolactam analog with the structure of [[(S, S) Pro-Leu (spiro-γ-lactam)]9,10, Trp11] Physalaemi ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2023 Creative Peptides. All rights reserved.